What medications should be given to a dialysis patient with a persistent cough who is on an ACE inhibitor and may have reflux or asthma?

Management of Persistent Cough in a Dialysis Patient on ACE Inhibitor

Discontinue the ACE inhibitor immediately and switch to an angiotensin receptor blocker (ARB), as ACE inhibitor-induced cough is the most likely primary cause and the only uniformly effective treatment is drug cessation. 1, 2

Step 1: Address the ACE Inhibitor

• Stop the ACE inhibitor as it causes cough in 5-10% of patients and is the most common reason for drug withdrawal 1
• Cough typically resolves within 1-4 weeks after discontinuation, though may take up to 3 months in some patients 2
• Switch to an ARB (such as candesartan 4-8 mg once daily, losartan 25-50 mg once daily, or valsartan 20-40 mg twice daily), which has similar efficacy for cardiovascular protection but cough incidence similar to placebo 1, 2
• Note: Dialysis patients have higher cough prevalence (22% in peritoneal dialysis vs 7% in hemodialysis), often associated with gastroesophageal reflux 3

Step 2: Treat Gastroesophageal Reflux (If Present)

Since reflux is suspected and is particularly common in dialysis patients 3:

• Implement lifestyle modifications first: head of bed elevation, avoid meals within 3 hours of bedtime, weight loss if overweight 4
• If heartburn/regurgitation present: Start proton pump inhibitor (omeprazole 20-40 mg twice daily or equivalent) taken before meals for at least 8 weeks 5
• Add prokinetic agent (metoclopramide 10 mg three times daily) if inadequate response 5
• Do NOT use PPI alone if no heartburn/regurgitation symptoms, as it is unlikely to be effective 4
• Eliminate medications worsening reflux: bisphosphonates, nitrates, calcium channel blockers, theophylline 5
• Expect cough improvement may take up to 3 months even after GI symptoms resolve 4

Step 3: Evaluate and Treat Asthma (If Suspected)

If cough persists after ACE inhibitor discontinuation and reflux treatment:

• Initial treatment: Inhaled corticosteroids plus inhaled bronchodilators 6
• If refractory: Add leukotriene receptor antagonist (LTRA) before escalating to systemic steroids 6
• For severe/refractory cases: Short course (1-2 weeks) of oral corticosteroids (prednisone 30-40 mg daily) followed by inhaled corticosteroids 6
• Note: Asthma is a risk factor for ACE inhibitor-induced cough, so underlying bronchial hyperreactivity should be investigated 7

Step 4: Consider Upper Airway Cough Syndrome

If prominent nasal symptoms exist:

• Trial of topical nasal corticosteroid for 1 month if upper airway symptoms present 5
• Evidence for antihistamines is conflicting in the UK, though they may have a role 5

Critical Pitfalls to Avoid

• Do not rechallenge with another ACE inhibitor unless there is compelling cardiovascular indication, as cough recurs within days and is considered a class effect 1, 2
• Do not use PPI monotherapy without lifestyle modifications and dietary changes, as trials show no benefit when used in isolation 4
• Do not assume single etiology: Multiple causes often coexist (reflux, asthma, upper airway disease) requiring simultaneous treatment 5, 8
• Do not continue ACE inhibitor while attempting symptomatic cough suppression—discontinuation is the only uniformly effective treatment 2

Timeline Expectations

• ACE inhibitor cough resolution: 1-4 weeks (up to 3 months in some cases) 2
• Reflux-related cough improvement: Up to 3 months 4
• Asthma treatment response: Partial improvement within 1 week, complete resolution may require up to 8 weeks 9